JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Meckel's enteroliths: clinical, radiologic, and pathologic findings.

OBJECTIVE: The objective of this study was to determine the clinical, radiographic, and pathologic findings of Meckel's enteroliths, a rare complication of Meckel's diverticulum.

MATERIALS AND METHODS: Of 84 cases of Meckel's diverticulum, eight (10%) were found at surgery to contain enteroliths. Abdominal radiographs and barium studies of these eight patients were reviewed retrospectively. Medical and pathologic records were also reviewed.

RESULTS: At the time of diagnosis, the median age of the eight patients with Meckel's enteroliths was 45 years old. Six patients were male, and two were female. All eight patients were symptomatic, but symptoms were chronic in six patients (75%). Meckel's enteroliths were seen on abdominal radiographs in seven patients (88%). The stones had an average diameter of 3 cm (range, 1-5 cm). Five patients had multiple opaque stones, and two patient had solitary stones (total number of stones, 18). Sixteen of the enteroliths were revealed as peripheral calcified stones with radiolucent centers; two were revealed as laminated stones. One patient had a Meckel's stone ileus due to extrusion of an enterolith into the lumen that subsequently caused small-bowel obstruction. Histologically, all Meckel's diverticula with enteroliths contained intestinal mucosa lining without ectopic gastric mucosa.

CONCLUSION: Meckel's enteroliths are a rare complication of Meckel's diverticulum. Nevertheless, this entity should be included in the differential diagnosis of abdominal calcification when a peripheral calcified stone or, less commonly, a laminated stone is detected in the lower abdomen on radiographs of adults with chronic abdominal pain or gastrointestinal blood loss.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app